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The role of L-DOPA in spinal nociceptive reflex activity has been 
re-evaluated. In high spinal cats, with supraspinal loops being 
excluded, the onset of reflex facilitation induced by noxious 
radiant heat is delayed after injection of L-DOPA by 4 to 10 s, i.e. 
the early component of nociceptive reflex facilitation is blocked, 
while the late component persisted. Further investigations have 
shown that the early component of reflex facilitation induced by 
noxious radiant heat is mediated by Aδ-fibres and the late 
component by C-fibres. Therefore, it can be assumed that  
L-DOPA, like opioids, preferentially blocks the transmission in 
nociceptive reflex pathways from Aδ-fibres. 
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In the beginning, the relation of L-DOPA to 
spinal nociceptive reflex activity has not been clearly 
defined. When Eccles and Lundberg (1959) introduced 
the term "flexor reflex afferents" (FRA, a term which is 
"really a misnomer", quoting Lundberg 1979, but without 
a better alternative) for “afferents which may evoke the 
flexion reflex” (within the title of the publication), they 
comprised low to medium threshold cutaneous afferents, 
joint afferents and medium to high threshold muscle 
afferents under this term but originally not nociceptive 
afferents (Lundberg 1982). Indeed, a contribution of 
nociceptive afferents to the quite unspecific FRA system 
was shown some time later by demonstrating a 
convergence from nociceptive cutaneous afferents onto 
common interneurones of non-nociceptive FRA (Steffens 
and Schomburg 1993). Furthermore, another 
characteristic of FRA also applies to nociceptive 
afferents, namely, that early polysynaptic spinal reflex 
pathways from these afferents are depressed by 
intravenous injection of L-DOPA (Andén et al. 1966, 
Lundberg 1982, Schomburg and Steffens 1998) with the 
exception of the excitatory nociceptive pathway from the 
foot pad to plantaris and intrinsic foot extensors 
(Schomburg and Steffens 1998).  
A further evaluation of the influence of L-DOPA 
on spinal nociceptive reflexes was performed in nine 
experiments with anaemically decapitated, high spinal 
cats, excluding supra-spinal influence and loops (for 
further technical details see Kniffki et al. 1981 and 
Schomburg and Steffens 1998). These experiments have 
shown that the facilitation during the early period of 
noxious heat application is more readily suppressed by  
L-DOPA than the facilitation during the later period. This 
is shown in Figure 1 A which is taken with modification 
from Schomburg and Steffens (1998). In the control 
before L-DOPA application the monosynaptic test reflex 
(reflex interval 2 s) from the posterior biceps 
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semitendinosus (PBSt) muscle started to increase in 
parallel with the background noise within 2 s after the 
onset of the conditioning noxious radiant heat stimulation 
(52 °C, lower traces in Fig. 1 A and B) at the central foot 
pad. After injection of L-DOPA (Fig. 1 B, 80 min after 
the i. v. injection of 100 mg L-DOPA/kg bodyweight) the 
PBSt test reflex and the background noise started to 
increase about 10 s after the onset of radiant heat  





Fig. 1. Depression of the early component of noxious heat 
induced facilitation of the monosynaptic reflex of PBSt by  
L-DOPA. (A) control, (B) 80 min after L-DOPA (100 mg/kg i. v.). 
Anaemically decapitated, high spinalised cat; monosynaptic 
reflexes evoked by electrical stimulation of the PBSt nerve 
(stimulus strength 5 times threshold) recorded from ventral roots 
L7/S1; noxious radiant heat (52 °C) applied to the central pad of 




The observed increase of the delay between the 
onset of noxious radiant heat and reflex facilitation from 
less than 2 s before the injection of L-DOPA to 4 to 10 s 
after the injection of L-DOPA in different experiments is 
much to long to be ascribed to the well-known release of 
the long latency FRA pathways by L-DOPA. The 
activation of these L-DOPA induced long latency FRA 
pathways, which emerge together with the blockade of 
the short latency FRA pathways, occurs with a latency of 
some 100 to 200 ms (Andén et al. 1966).  
Originally, the observed phenomenon of an 
increased time lag of nociceptive reflex facilitation after 
L-DOPA was just interpreted as an increase of the delay of 
the reflex action of noxious radiant heat (Schomburg and 
Steffens 1998). However, results of subsequent 
experiments with a blockade of Aδ-fibres by TTX now 
allow another interpretation. After local application of 
TTX at the afferent nerve (tibial nerve from the foot sole), 
which leads to a block of the conduction in Aδ-fibres but 
leaves conduction in TTX resistant C-fibres intact 
(Schomburg et al. 2000, 2011, Kimura and Kontani 2008), 
the latency of the conditioning effect of noxious radiant 
heat onto monosynaptic test reflexes of hindlimb muscles 
increased by around 5±2 s (Schomburg et al. 2000). This is 
in the same range as the increase of the delay of reflex 
facilitation observed after application of L-DOPA and after 
application of opioids (Schomburg et al. 2011). Therefore, 
it can be assumed that L-DOPA, like opioids, blocks the 
transmission in nociceptive reflex pathways from Aδ fibre-
afferents more readily than in those from C fibre-afferents. 
When the sensitivity to L-DOPA is taken as a criterion for 
the attribution of a pathway to the FRA system (Andén et 
al. 1966, Lundberg 1982, Schomburg 1990), mainly the 
nociceptive Aδ-afferents seem to be related to the FRA 
system. 
Interestingly, nonmotor symptoms of patients 
with Parkinson disease including pain or aching also 
respond to dopaminergic treatment (Stacy et al. 2010). 
Furthermore, dopaminergic treatment appears to improve 
chronic pain symptoms in patients with fibromyalgia 
(Holman and Myers 2005). With regard to the anti-
nociceptive mechanism of L-DOPA, the dopamine D2 
receptor in the brain seems to have a crucial role in pain 
modulation (Hagelberg et al. 2002). In addition, 
experiments with intrathecal co-administration of 
substance P and L-DOPA confirm the crucial role of the 
D2 receptor in attenuating pain transmission at the spinal 
level (Shimizu et al. 2004). The spinal anti-nociceptive 
influence of L-DOPA has been confirmed by recent 
electrophysiological studies on substantia gelatinosa 
neurones which revealed inhibitory effects by D2-like 
receptors in the rat spinal cord (Tamae et al. 2005).   
The experiments were performed according to 
the ethical guidelines of the national animal protection 
law and were authorised by the ethical committee of the 
University of Göttingen. 
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